PFA
IONS icon

Pure Financial Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Pure Financial Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,110
Closed -$439K – 63
2014
Q4 		$439K Buy
+7,110
New +$351K 0.15% 39

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pure Financial Advisors's IONS Position: Q1 2015 in Review

Pure Financial Advisors sold out of Ionis Pharmaceuticals (IONS) in Q1 2015, closing a stake of 7,110 shares — an estimated $439K sold.

Pure Financial Advisors first reported a position in IONS in Q4 2014 and held it in 1 quarter. The position peaked at $439K in Q4 2014. 339 funds tracked by Wall St. Rank hold IONS as of Q1 2015.

  • Pure Financial Advisors reported no remaining Ionis Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Pure Financial Advisors sold 7,110 Ionis Pharmaceuticals shares in Q1 2015, an estimated $439K.
  • Pure Financial Advisors first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Pure Financial Advisors's Ionis Pharmaceuticals position peaked at $439K in Q4 2014.
  • 339 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2015.

Based on Pure Financial Advisors's 13F filing for Q1 2015, filed 6 Apr 2015.